Treatment of advanced cancer of the prostate
Orovan, W.L.
Canadian Journal of Surgery. Journal Canadien de Chirurgie 32(5): 315-316
1989
ISSN/ISBN: 0008-428X PMID: 2670160 Document Number: 340877
Document emailed within 1 workday
Related Documents
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352Faris, G.; Stein, A.; Lurie, A. 1993: Hormonal treatment of advanced prostate cancer Harefuah 124(1): 35-40
Mulders, P.F. 1999: Treatment of advanced prostate cancer: the vaccine approach Scandinavian Journal of Urology and Nephrology. Supplementum 203: 41-43
Swanson, G.P. 2007: Treatment options in locally advanced prostate cancer Minerva Urologica e Nefrologica 59(1): 27-42
Kurokawa, K.; Suzuki, K.; Yamanaka, H. 2003: Treatment strategy for locally advanced prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(1): 38-42
Azuma, H.; Katsuoka, Y. 2006: Treatment for locally advanced prostate cancer: value of surgery Hinyokika Kiyo. Acta Urologica Japonica 52(6): 459-467
Wenderoth, U.K.; Jacobi, G.H. 1986: Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin Annales d'Urologie 20(2): 95-97
Pavone-Macaluso, M.; Serretta, V.; Pavone, C.; Romano, C.; Daricello, G. 1989: Antiandrogens in monotherapy or combined therapy for treatment of advanced cancer of the prostate Archivos Espanoles de Urologia 42(Suppl 2): 197-205
Kelly, W.K.; Slovin, S.; Scher, H.I. 1996: Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 8-14
Fitzpatrick, J.M. 1996: Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: the argument against European Urology 29(Suppl): 37-39
Bourlon, M.ía.T.; Mora, M.; Hinojosa-Fano, J.; Martínez-Benitez, B.; Amini, A.; Castillejos-Molina, R.; Glodé, L.M. 2016: Man with Locally Advanced, High-Risk Prostate Cancer Asks about Adding Chemotherapy to his Treatment Oncology 30(1): 94-98
Neri, B.; Bartalucci, S.; Pieri, A.; Gemelli, M.T.; Rizzo, M.; Bartoletti, R.; Trippitelli, A.; Paoletti, M.C. 1989: Complete androgen blockade as treatment for advanced prostate cancer: clinical response and side-effects Anticancer Research 9(1): 13-16
Shore, N.D.; Sieber, P.; Schimke, L.; Perzin, A.; Olsen, S. 2013: Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer Urologic Nursing 33(5): 236-44 248
Utomo, N.B.; Mochtar, C.A.; Umbas, R. 2012: Primary hormonal treatment in localized and locally advanced prostate cancer: effectiveness and survival predictive factors Acta Medica Indonesiana 44(1): 10-15
Small, E.J.; Dawson, N.A.; Kantoff, P.W.; Vogelzang, N.J. 1996: Cancer and Leukemia Group B trials for advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 28-31
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Fournier, G. 1994: Management of advanced prostate cancer La Revue du Praticien 44(5): 595-600
Baltogiannis, D.; Giannakopoulos, X.; Charalabopoulos, K.; Sofikitis, N. 2004: Monotherapy in advanced prostate cancer: an overview Experimental Oncology 26(3): 185-191
Olapade-Olaopa, E.O.; Obamuyide, H.A.; Yisa, G.T. 2008: Management of advanced prostate cancer in Africa Canadian Journal of Urology 15(1): 3890-3898
Fosså, S.D. 1996: Quality of life in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 32-34